Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patellofemoral Joint | 20 | 2023 | 66 | 10.870 |
Why?
|
Joint Instability | 21 | 2023 | 397 | 7.390 |
Why?
|
Knee Joint | 61 | 2023 | 756 | 7.340 |
Why?
|
Cartilage, Articular | 30 | 2023 | 426 | 6.870 |
Why?
|
Patella | 16 | 2023 | 72 | 4.680 |
Why?
|
Patellar Dislocation | 8 | 2023 | 23 | 4.380 |
Why?
|
Cartilage Diseases | 17 | 2023 | 95 | 3.970 |
Why?
|
Allografts | 32 | 2023 | 222 | 3.870 |
Why?
|
Knee Injuries | 16 | 2023 | 207 | 3.710 |
Why?
|
Anterior Cruciate Ligament Reconstruction | 19 | 2023 | 203 | 3.640 |
Why?
|
Rotator Cuff Injuries | 12 | 2023 | 316 | 3.260 |
Why?
|
Shoulder Joint | 17 | 2023 | 648 | 3.070 |
Why?
|
Osteoarthritis, Knee | 19 | 2022 | 364 | 2.960 |
Why?
|
Bone Transplantation | 17 | 2023 | 221 | 2.950 |
Why?
|
Ligaments, Articular | 16 | 2023 | 111 | 2.900 |
Why?
|
Humans | 157 | 2023 | 28413 | 2.870 |
Why?
|
Menisci, Tibial | 22 | 2022 | 178 | 2.780 |
Why?
|
Arthroscopy | 31 | 2023 | 1088 | 2.680 |
Why?
|
Tibial Meniscus Injuries | 8 | 2022 | 87 | 2.650 |
Why?
|
Platelet-Rich Plasma | 7 | 2023 | 86 | 2.570 |
Why?
|
Femur | 15 | 2022 | 400 | 2.460 |
Why?
|
Patellar Ligament | 5 | 2023 | 42 | 2.360 |
Why?
|
Anterior Cruciate Ligament Injuries | 12 | 2023 | 196 | 2.240 |
Why?
|
Cadaver | 19 | 2023 | 389 | 2.210 |
Why?
|
Tendons | 11 | 2023 | 225 | 2.010 |
Why?
|
Transplantation, Homologous | 25 | 2023 | 286 | 1.960 |
Why?
|
Retrospective Studies | 44 | 2023 | 3613 | 1.820 |
Why?
|
Cartilage | 9 | 2022 | 103 | 1.810 |
Why?
|
Tomography, X-Ray Computed | 13 | 2020 | 770 | 1.700 |
Why?
|
Intra-Articular Fractures | 4 | 2022 | 21 | 1.640 |
Why?
|
Tendon Injuries | 6 | 2022 | 212 | 1.640 |
Why?
|
Osteotomy | 13 | 2022 | 174 | 1.600 |
Why?
|
Bankart Lesions | 2 | 2023 | 14 | 1.600 |
Why?
|
Rotator Cuff | 9 | 2023 | 297 | 1.580 |
Why?
|
Adult | 62 | 2023 | 8146 | 1.580 |
Why?
|
Tenodesis | 7 | 2023 | 174 | 1.500 |
Why?
|
Biomechanical Phenomena | 14 | 2023 | 676 | 1.470 |
Why?
|
Tibia | 15 | 2022 | 258 | 1.430 |
Why?
|
Quadriceps Muscle | 2 | 2020 | 32 | 1.360 |
Why?
|
Fractures, Stress | 3 | 2020 | 21 | 1.330 |
Why?
|
Chondrocytes | 7 | 2022 | 156 | 1.320 |
Why?
|
Patient Reported Outcome Measures | 21 | 2023 | 506 | 1.280 |
Why?
|
Magnetic Resonance Imaging | 13 | 2023 | 1197 | 1.250 |
Why?
|
Anterior Cruciate Ligament | 7 | 2022 | 185 | 1.240 |
Why?
|
Young Adult | 31 | 2023 | 2102 | 1.230 |
Why?
|
Adolescent | 28 | 2023 | 2318 | 1.200 |
Why?
|
Arthroplasty, Subchondral | 3 | 2018 | 30 | 1.190 |
Why?
|
Return to Sport | 9 | 2020 | 158 | 1.180 |
Why?
|
Bone Marrow | 6 | 2023 | 81 | 1.130 |
Why?
|
Treatment Outcome | 38 | 2023 | 3619 | 1.120 |
Why?
|
Suture Anchors | 4 | 2023 | 100 | 1.070 |
Why?
|
Middle Aged | 48 | 2022 | 9308 | 1.070 |
Why?
|
Male | 62 | 2023 | 15338 | 1.060 |
Why?
|
Meniscus | 3 | 2023 | 20 | 1.050 |
Why?
|
Imaging, Three-Dimensional | 11 | 2020 | 235 | 1.040 |
Why?
|
Computer Simulation | 4 | 2021 | 204 | 1.030 |
Why?
|
Female | 59 | 2023 | 15762 | 1.010 |
Why?
|
Bone-Patellar Tendon-Bone Grafting | 4 | 2023 | 34 | 1.000 |
Why?
|
Quality of Life | 8 | 2022 | 663 | 0.990 |
Why?
|
Arthroplasty, Replacement, Knee | 8 | 2023 | 624 | 0.990 |
Why?
|
Return to Work | 6 | 2020 | 65 | 0.970 |
Why?
|
Bone Diseases | 2 | 2022 | 26 | 0.950 |
Why?
|
Shoulder | 8 | 2022 | 190 | 0.940 |
Why?
|
Activities of Daily Living | 7 | 2022 | 611 | 0.880 |
Why?
|
Suture Techniques | 6 | 2023 | 157 | 0.870 |
Why?
|
Arthritis | 2 | 2022 | 53 | 0.860 |
Why?
|
Follow-Up Studies | 23 | 2022 | 1870 | 0.840 |
Why?
|
Scapula | 3 | 2019 | 91 | 0.830 |
Why?
|
Shoulder Dislocation | 2 | 2022 | 111 | 0.830 |
Why?
|
Musculoskeletal Diseases | 1 | 2023 | 46 | 0.820 |
Why?
|
Pain | 12 | 2023 | 406 | 0.790 |
Why?
|
Surgeons | 2 | 2021 | 89 | 0.770 |
Why?
|
Range of Motion, Articular | 11 | 2022 | 725 | 0.750 |
Why?
|
Second-Look Surgery | 3 | 2020 | 13 | 0.750 |
Why?
|
Orthopedic Procedures | 8 | 2020 | 312 | 0.750 |
Why?
|
Meniscectomy | 3 | 2020 | 27 | 0.730 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2022 | 7 | 0.700 |
Why?
|
Hyaline Cartilage | 2 | 2017 | 15 | 0.690 |
Why?
|
Humeral Head | 3 | 2022 | 37 | 0.670 |
Why?
|
Tissue Adhesives | 1 | 2019 | 8 | 0.640 |
Why?
|
Reoperation | 15 | 2021 | 917 | 0.630 |
Why?
|
Bone Resorption | 1 | 2019 | 85 | 0.610 |
Why?
|
Reproducibility of Results | 8 | 2021 | 727 | 0.600 |
Why?
|
Stifle | 1 | 2018 | 10 | 0.590 |
Why?
|
Pain, Postoperative | 6 | 2022 | 316 | 0.580 |
Why?
|
Femur Head | 2 | 2015 | 71 | 0.580 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 88 | 0.570 |
Why?
|
Osteoporosis | 1 | 2018 | 77 | 0.560 |
Why?
|
Minimal Clinically Important Difference | 5 | 2022 | 166 | 0.550 |
Why?
|
Transplantation, Autologous | 8 | 2023 | 168 | 0.540 |
Why?
|
Animals | 11 | 2023 | 3808 | 0.530 |
Why?
|
Osteolysis | 1 | 2016 | 144 | 0.490 |
Why?
|
Postoperative Period | 10 | 2020 | 331 | 0.490 |
Why?
|
Femoracetabular Impingement | 3 | 2020 | 373 | 0.460 |
Why?
|
Wound Healing | 4 | 2023 | 160 | 0.450 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 215 | 0.430 |
Why?
|
Osteochondritis Dissecans | 3 | 2019 | 25 | 0.430 |
Why?
|
Gamma Rays | 1 | 2013 | 17 | 0.420 |
Why?
|
Arm | 3 | 2022 | 84 | 0.420 |
Why?
|
Patient Satisfaction | 7 | 2021 | 331 | 0.410 |
Why?
|
Sheep | 2 | 2023 | 19 | 0.410 |
Why?
|
Muscle, Skeletal | 4 | 2022 | 398 | 0.410 |
Why?
|
Computers | 2 | 2022 | 22 | 0.390 |
Why?
|
Growth Plate | 2 | 2020 | 16 | 0.350 |
Why?
|
Biological Products | 2 | 2023 | 45 | 0.350 |
Why?
|
Risk Factors | 6 | 2021 | 2413 | 0.340 |
Why?
|
Amniotic Fluid | 2 | 2019 | 3 | 0.330 |
Why?
|
Aged | 15 | 2021 | 9314 | 0.330 |
Why?
|
Sports Medicine | 2 | 2022 | 37 | 0.320 |
Why?
|
Psychometrics | 2 | 2020 | 244 | 0.310 |
Why?
|
Radiography | 3 | 2021 | 652 | 0.290 |
Why?
|
Amnion | 2 | 2018 | 4 | 0.290 |
Why?
|
Prospective Studies | 9 | 2023 | 1801 | 0.270 |
Why?
|
Hyaluronic Acid | 4 | 2021 | 56 | 0.270 |
Why?
|
Athletic Injuries | 4 | 2019 | 175 | 0.260 |
Why?
|
Collagen | 3 | 2023 | 84 | 0.260 |
Why?
|
Joint Diseases | 2 | 2020 | 113 | 0.260 |
Why?
|
Bone and Bones | 2 | 2018 | 120 | 0.260 |
Why?
|
Shoulder Injuries | 3 | 2019 | 147 | 0.250 |
Why?
|
Recurrence | 3 | 2021 | 320 | 0.250 |
Why?
|
Survivorship | 2 | 2023 | 20 | 0.250 |
Why?
|
Child | 4 | 2022 | 1423 | 0.250 |
Why?
|
Weight-Bearing | 2 | 2018 | 171 | 0.240 |
Why?
|
Shoulder Pain | 2 | 2020 | 57 | 0.240 |
Why?
|
Cohort Studies | 8 | 2023 | 1935 | 0.230 |
Why?
|
Ligaments | 1 | 2023 | 15 | 0.220 |
Why?
|
Injections, Intra-Articular | 6 | 2021 | 91 | 0.220 |
Why?
|
Arthroplasty | 2 | 2023 | 150 | 0.220 |
Why?
|
Debridement | 3 | 2018 | 102 | 0.210 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2020 | 32 | 0.210 |
Why?
|
Bone Screws | 2 | 2023 | 151 | 0.200 |
Why?
|
Autografts | 2 | 2023 | 31 | 0.200 |
Why?
|
Ossification, Heterotopic | 1 | 2022 | 36 | 0.200 |
Why?
|
Posterior Cruciate Ligament Reconstruction | 1 | 2022 | 8 | 0.200 |
Why?
|
Neurosurgical Procedures | 1 | 2023 | 128 | 0.200 |
Why?
|
Time Factors | 5 | 2019 | 1499 | 0.190 |
Why?
|
Clinical Trials as Topic | 3 | 2018 | 236 | 0.190 |
Why?
|
Fractures, Bone | 1 | 2023 | 75 | 0.190 |
Why?
|
Electrosurgery | 1 | 2021 | 5 | 0.190 |
Why?
|
Glenoid Cavity | 1 | 2022 | 39 | 0.190 |
Why?
|
Surgical Instruments | 1 | 2021 | 25 | 0.190 |
Why?
|
Tendinopathy | 2 | 2015 | 54 | 0.190 |
Why?
|
Rotation | 1 | 2021 | 142 | 0.180 |
Why?
|
Network Meta-Analysis | 2 | 2021 | 32 | 0.180 |
Why?
|
Epiphyses | 1 | 2020 | 12 | 0.180 |
Why?
|
Perioperative Period | 1 | 2020 | 9 | 0.180 |
Why?
|
Postoperative Complications | 4 | 2020 | 935 | 0.170 |
Why?
|
Knee | 1 | 2020 | 46 | 0.170 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 51 | 0.170 |
Why?
|
Viscosupplements | 1 | 2019 | 10 | 0.170 |
Why?
|
Cattle | 2 | 2018 | 126 | 0.170 |
Why?
|
Genu Varum | 1 | 2019 | 4 | 0.170 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 58 | 0.160 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 939 | 0.160 |
Why?
|
Desiccation | 1 | 2019 | 3 | 0.160 |
Why?
|
Motion Therapy, Continuous Passive | 1 | 2019 | 6 | 0.160 |
Why?
|
Chorion | 1 | 2018 | 2 | 0.160 |
Why?
|
Umbilical Cord | 1 | 2018 | 4 | 0.160 |
Why?
|
Pain Measurement | 5 | 2020 | 473 | 0.160 |
Why?
|
Guided Tissue Regeneration | 1 | 2018 | 11 | 0.160 |
Why?
|
Leukocytes | 2 | 2016 | 38 | 0.160 |
Why?
|
Software | 1 | 2019 | 67 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 69 | 0.150 |
Why?
|
Humerus | 2 | 2020 | 120 | 0.150 |
Why?
|
Tissue Banks | 1 | 2018 | 6 | 0.150 |
Why?
|
Anesthetics, Local | 2 | 2009 | 80 | 0.150 |
Why?
|
Arthralgia | 4 | 2020 | 125 | 0.150 |
Why?
|
Bone Marrow Transplantation | 1 | 2017 | 26 | 0.150 |
Why?
|
Multivariate Analysis | 4 | 2020 | 334 | 0.140 |
Why?
|
Posterior Cruciate Ligament | 2 | 2019 | 24 | 0.140 |
Why?
|
Quality Improvement | 1 | 2018 | 161 | 0.140 |
Why?
|
Research Design | 1 | 2018 | 208 | 0.140 |
Why?
|
Athletes | 1 | 2017 | 89 | 0.130 |
Why?
|
Sodium Chloride | 1 | 2016 | 36 | 0.130 |
Why?
|
Rupture | 2 | 2014 | 114 | 0.130 |
Why?
|
Bone Malalignment | 1 | 2016 | 20 | 0.130 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 43 | 0.130 |
Why?
|
Soft Tissue Injuries | 1 | 2016 | 21 | 0.130 |
Why?
|
ROC Curve | 3 | 2020 | 145 | 0.130 |
Why?
|
Time-to-Treatment | 1 | 2015 | 35 | 0.120 |
Why?
|
Disease Models, Animal | 1 | 2018 | 629 | 0.120 |
Why?
|
Graft Survival | 4 | 2017 | 102 | 0.120 |
Why?
|
Orthopedics | 1 | 2016 | 113 | 0.120 |
Why?
|
Ontario | 3 | 2020 | 15 | 0.120 |
Why?
|
Tissue Donors | 2 | 2019 | 81 | 0.120 |
Why?
|
Sex Characteristics | 1 | 2015 | 121 | 0.110 |
Why?
|
Cryopreservation | 2 | 2018 | 17 | 0.110 |
Why?
|
Preoperative Period | 3 | 2020 | 81 | 0.110 |
Why?
|
Lacerations | 1 | 2013 | 18 | 0.110 |
Why?
|
Hip Injuries | 1 | 2013 | 17 | 0.110 |
Why?
|
Elbow Joint | 1 | 2015 | 125 | 0.110 |
Why?
|
Pectoralis Muscles | 1 | 2013 | 18 | 0.110 |
Why?
|
Proteoglycans | 3 | 2022 | 136 | 0.110 |
Why?
|
Stress, Mechanical | 1 | 2013 | 170 | 0.110 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 30 | 0.100 |
Why?
|
Tendon Transfer | 1 | 2012 | 20 | 0.100 |
Why?
|
Recovery of Function | 3 | 2020 | 300 | 0.100 |
Why?
|
Postoperative Care | 2 | 2013 | 140 | 0.100 |
Why?
|
Popliteal Vein | 1 | 2012 | 2 | 0.100 |
Why?
|
Popliteal Artery | 1 | 2012 | 3 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2012 | 27 | 0.100 |
Why?
|
Tissue Transplantation | 2 | 2008 | 18 | 0.100 |
Why?
|
Baseball | 1 | 2013 | 102 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2012 | 67 | 0.090 |
Why?
|
Heart Arrest | 1 | 2012 | 38 | 0.090 |
Why?
|
Upper Extremity | 2 | 2021 | 64 | 0.090 |
Why?
|
Acetabulum | 1 | 2012 | 235 | 0.090 |
Why?
|
Visual Analog Scale | 2 | 2020 | 84 | 0.080 |
Why?
|
Odds Ratio | 2 | 2020 | 275 | 0.080 |
Why?
|
Methylprednisolone | 1 | 2009 | 20 | 0.080 |
Why?
|
Lidocaine | 1 | 2009 | 24 | 0.080 |
Why?
|
Tissue Engineering | 1 | 2008 | 32 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 179 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 184 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2009 | 80 | 0.080 |
Why?
|
Surveys and Questionnaires | 3 | 2020 | 1212 | 0.080 |
Why?
|
Bupivacaine | 1 | 2008 | 45 | 0.080 |
Why?
|
United States | 3 | 2021 | 2177 | 0.070 |
Why?
|
Freezing | 1 | 2008 | 13 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 57 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 75 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2008 | 58 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 93 | 0.070 |
Why?
|
Tissue Scaffolds | 2 | 2020 | 28 | 0.060 |
Why?
|
Prostheses and Implants | 1 | 2006 | 163 | 0.060 |
Why?
|
Incidence | 2 | 2018 | 771 | 0.060 |
Why?
|
Radiostereometric Analysis | 1 | 2023 | 7 | 0.050 |
Why?
|
Treatment Failure | 2 | 2018 | 163 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2022 | 23 | 0.050 |
Why?
|
Documentation | 1 | 2022 | 29 | 0.050 |
Why?
|
Elbow | 1 | 2021 | 49 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 111 | 0.050 |
Why?
|
Information Systems | 1 | 2021 | 25 | 0.050 |
Why?
|
Workers' Compensation | 1 | 2021 | 70 | 0.040 |
Why?
|
Area Under Curve | 1 | 2020 | 63 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 117 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 71 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2020 | 20 | 0.040 |
Why?
|
Sports | 1 | 2020 | 60 | 0.040 |
Why?
|
Morphine | 1 | 2020 | 61 | 0.040 |
Why?
|
Rehabilitation | 1 | 2019 | 14 | 0.040 |
Why?
|
Survival Rate | 1 | 2021 | 356 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2019 | 111 | 0.040 |
Why?
|
Logistic Models | 1 | 2020 | 399 | 0.040 |
Why?
|
Fracture Fixation, Internal | 1 | 2019 | 63 | 0.040 |
Why?
|
Ankle | 1 | 2019 | 24 | 0.040 |
Why?
|
Regression Analysis | 2 | 2010 | 267 | 0.040 |
Why?
|
Aggrecans | 1 | 2019 | 54 | 0.040 |
Why?
|
Ankle Joint | 1 | 2019 | 45 | 0.040 |
Why?
|
Lysholm Knee Score | 1 | 2018 | 8 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 31 | 0.040 |
Why?
|
Joint Dislocations | 1 | 2019 | 55 | 0.040 |
Why?
|
Research Subjects | 1 | 2018 | 11 | 0.040 |
Why?
|
Demography | 1 | 2018 | 75 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 692 | 0.040 |
Why?
|
Multipotent Stem Cells | 1 | 2017 | 1 | 0.040 |
Why?
|
Chondrogenesis | 1 | 2017 | 30 | 0.040 |
Why?
|
Body Mass Index | 1 | 2020 | 467 | 0.040 |
Why?
|
Biocompatible Materials | 2 | 2008 | 95 | 0.030 |
Why?
|
Osteogenesis | 1 | 2017 | 114 | 0.030 |
Why?
|
Contraindications | 1 | 2016 | 33 | 0.030 |
Why?
|
Orthopedic Fixation Devices | 1 | 2016 | 20 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2017 | 604 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 4880 | 0.030 |
Why?
|
Physical Examination | 1 | 2016 | 119 | 0.030 |
Why?
|
Arthroplasty, Replacement, Shoulder | 1 | 2017 | 207 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2017 | 1378 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2013 | 9 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2013 | 234 | 0.030 |
Why?
|
Acute Disease | 1 | 2013 | 204 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2012 | 22 | 0.020 |
Why?
|
Models, Biological | 1 | 2013 | 329 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 125 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 673 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2010 | 277 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2010 | 75 | 0.020 |
Why?
|
Body Height | 1 | 2009 | 37 | 0.020 |
Why?
|
Prosthesis Fitting | 1 | 2009 | 21 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2009 | 44 | 0.020 |
Why?
|
Chondromalacia Patellae | 1 | 2009 | 4 | 0.020 |
Why?
|
Organ Size | 1 | 2009 | 108 | 0.020 |
Why?
|
Anesthetics | 1 | 2009 | 23 | 0.020 |
Why?
|
Body Weight | 1 | 2009 | 145 | 0.020 |
Why?
|
Models, Statistical | 1 | 2009 | 128 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2008 | 12 | 0.020 |
Why?
|
Substance P | 1 | 2008 | 12 | 0.020 |
Why?
|
Axons | 1 | 2008 | 28 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2008 | 35 | 0.020 |
Why?
|
Graft Rejection | 1 | 2008 | 71 | 0.020 |
Why?
|
Random Allocation | 1 | 2008 | 129 | 0.020 |
Why?
|
Rabbits | 1 | 2008 | 192 | 0.020 |
Why?
|
Hot Temperature | 1 | 2008 | 19 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2008 | 17 | 0.020 |
Why?
|
Compressive Strength | 1 | 2008 | 25 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2009 | 425 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2008 | 51 | 0.020 |
Why?
|
Sex Factors | 1 | 2009 | 480 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2008 | 364 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 518 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2008 | 539 | 0.020 |
Why?
|
Polyurethanes | 1 | 2006 | 8 | 0.020 |
Why?
|
Polycarboxylate Cement | 1 | 2006 | 8 | 0.020 |
Why?
|
Connective Tissue | 1 | 2006 | 23 | 0.020 |
Why?
|
Chronic Disease | 1 | 2008 | 443 | 0.020 |
Why?
|
Models, Animal | 1 | 2006 | 120 | 0.020 |
Why?
|
Hip Joint | 1 | 2012 | 549 | 0.020 |
Why?
|
Palliative Care | 1 | 2007 | 109 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 826 | 0.020 |
Why?
|
Materials Testing | 1 | 2006 | 139 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 339 | 0.020 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2008 | 318 | 0.010 |
Why?
|
Rats | 1 | 2006 | 678 | 0.010 |
Why?
|
Algorithms | 1 | 2007 | 378 | 0.010 |
Why?
|